Inverse Relationship Between Obesity and FTO Gene Expression in Visceral Adipose Tissue in Humans

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2008 Feb 6

PMID 18251005

Citations 54

Authors

N Kloting

D Schleinitz

K Ruschke

J Berndt

M Fasshauer

A Tonjes

M R Schon

P Kovacs

M Stumvoll

M Bluher

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Recently, FTO was identified as a candidate gene contributing to both childhood and severe adult obesity. We tested the hypothesis that mRNA expression of FTO and/or of the neighbouring RPGRIP1L in adipose tissue correlates with measures of obesity and fat distribution. We also investigated whether the FTO obesity risk alleles might explain variability in FTO and RPGRIP1L mRNA expression.

Methods: In paired samples of visceral and subcutaneous adipose tissue from 55 lean and obese participants, we investigated whether FTO and RPGRIP1L mRNA expression is fat depot-specific, altered in obesity and related to measures of fat accumulation, insulin sensitivity and glucose metabolism. All participants were genotyped for the obesity-associated rs8050136 FTO variant.

Results: FTO mRNA expression was threefold higher in subcutaneous than in visceral adipose tissue. Subcutaneous FTO expression correlated with visceral FTO expression. FTO gene expression in both depots correlated with age and was negatively correlated to BMI and per cent body fat. FTO mRNA levels were not related to measures of insulin sensitivity and glucose metabolism. RPGRIP1L mRNA expression was 1.6-fold higher in visceral than in subcutaneous adipose tissue, but did not correlate with anthropometric and metabolic characteristics. There was no association between rs8050136 and FTO or RPGRIP1L mRNA expression in adipose tissue.

Conclusions/interpretation: Expression of adipose tissue FTO mRNA is fat depot-specific and negatively correlates with measures of obesity. However, the direction of this relationship still needs to be elucidated.

Citing Articles

An obesogenic FTO allele causes accelerated development, growth and insulin resistance in human skeletal muscle cells.

Guang L, Ma S, Yao Z, Song D, Chen Y, Liu S Nat Commun. 2025; 16(1):1645.

PMID: 40055326 PMC: 11889117. DOI: 10.1038/s41467-024-53820-2.

Association between Fat Mass and Obesity-Related Transcript Polymorphisms and Osteoporosis Phenotypes.

De Dios K, Huynh N, Tran T, Center J, Nguyen T J Bone Metab. 2024; 31(1):48-55.

PMID: 38485241 PMC: 10940110. DOI: 10.11005/jbm.2024.31.1.48.

Epitranscriptomics in metabolic disease.

Matsumura Y, Wei F, Sakai J Nat Metab. 2023; 5(3):370-384.

PMID: 36959512 DOI: 10.1038/s42255-023-00764-4.

The importance of considering regulatory domains in genome-wide analyses - the nearest gene is often wrong!.

Chua E, Yasar S, Harmston N Biol Open. 2022; 11(4).

PMID: 35377406 PMC: 9002814. DOI: 10.1242/bio.059091.

m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.

Ronningen T, Dahl M, Valderhaug T, Cayir A, Keller M, Tonjes A Front Endocrinol (Lausanne). 2021; 12:778875.

PMID: 34950106 PMC: 8689137. DOI: 10.3389/fendo.2021.778875.

References

Maes H, Neale M, Eaves L . Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997; 27(4):325-51. DOI: 10.1023/a:1025635913927. View

Arts H, Doherty D, van Beersum S, Parisi M, Letteboer S, Gorden N . Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome. Nat Genet. 2007; 39(7):882-8. DOI: 10.1038/ng2069. View

Klein S, Fontana L, Young V, Coggan A, Kilo C, Patterson B . Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004; 350(25):2549-57. DOI: 10.1056/NEJMoa033179. View

Stratakis C, Lafferty A, Taymans S, Gafni R, Meck J, Blancato J . Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13.... J Clin Endocrinol Metab. 2000; 85(9):3396-401. DOI: 10.1210/jcem.85.9.6776. View

Van der Hoeven F, Schimmang T, Volkmann A, Mattei M, Kyewski B, Ruther U . Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development. 1994; 120(9):2601-7. DOI: 10.1242/dev.120.9.2601. View

Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon M . Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005; 54(10):2911-6. DOI: 10.2337/diabetes.54.10.2911. View

Wajchenberg B . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2001; 21(6):697-738. DOI: 10.1210/edrv.21.6.0415. View

Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P . Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39(6):724-6. DOI: 10.1038/ng2048. View

Kloting N, Graham T, Berndt J, Kralisch S, Kovacs P, Wason C . Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 2007; 6(1):79-87. DOI: 10.1016/j.cmet.2007.06.002. View

10.

Scuteri A, Sanna S, Chen W, Uda M, Albai G, Strait J . Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3(7):e115. PMC: 1934391. DOI: 10.1371/journal.pgen.0030115. View

11.

Delous M, Baala L, Salomon R, Laclef C, Vierkotten J, Tory K . The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet. 2007; 39(7):875-81. DOI: 10.1038/ng2039. View

12.

Frayn K . Visceral fat and insulin resistance--causative or correlative?. Br J Nutr. 2000; 83 Suppl 1:S71-7. DOI: 10.1017/s0007114500000982. View

13.

Peters T, Ausmeier K, Ruther U . Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome. 1999; 10(10):983-6. DOI: 10.1007/s003359901144. View

14.

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

15.

Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P . A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002; 26(2):193-9. DOI: 10.1038/sj.ijo.0801871. View

16.

Gerken T, Girard C, Tung Y, Webby C, Saudek V, Hewitson K . The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007; 318(5855):1469-72. PMC: 2668859. DOI: 10.1126/science.1151710. View

17.

DeFronzo R, Tobin J, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237(3):E214-23. DOI: 10.1152/ajpendo.1979.237.3.E214. View

18.

Groop L . From fused toes in mice to human obesity. Nat Genet. 2007; 39(6):706-7. DOI: 10.1038/ng0607-706. View